Literature DB >> 226848

Increased resistance to influenza as a possible source of heterozygote advantage in cystic fibrosis.

W T Shier.   

Abstract

Cystic fibrosis is the most common lethal or semi-lethal genetic disease in Caucasians of Central European origin, among whom it is inherited as an autosomal recessive trait at a frequency approximately 10 times that expected from recurrent mutation alone. A decreased sialic acid content has been observed in cell surface glycoproteins on cystic fibrosis fibroblasts and in numerous soluble glycoprotein preparations from cystic fibrosis homozygotes. Sialic acid residues on cell surface glycoconjugates play an essential role in the binding and infectivity of myxoviruses and paramyxoviruses, including those causing pandemic influenza. It is suggested that increased resistance to these viruses conferred by similar but quantitatively smaller alterations in sialoglycoconjugate structure in cystic fibrosis heterozygotes may have provided a selective advantage to maintain the high frequency of the cystic fibrosis gene in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226848     DOI: 10.1016/0306-9877(79)90087-2

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers.

Authors:  L B Jorde; G M Lathrop
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

Review 2.  Clinical Phenotypes of Cystic Fibrosis Carriers.

Authors:  Philip M Polgreen; Alejandro P Comellas
Journal:  Annu Rev Med       Date:  2022-01-27       Impact factor: 13.739

Review 3.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

4.  Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles.

Authors:  Ashley J R Carter; Andrew Q Nguyen
Journal:  BMC Med Genet       Date:  2011-12-12       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.